{"title":"Non-invasive Dry Eye detection using Fuzzy c-means Clustering Algorithm","authors":"I.Ch, ra, N.Prabhakaran, V.Prabhu, S.Harshavardhan, N.Duraichi","doi":"10.35841/0970-938X.S1-S5","DOIUrl":"https://doi.org/10.35841/0970-938X.S1-S5","url":null,"abstract":"The background includes the study area of the dry eye taken from 75 patients to analyze eye-related disease. This method suggested as earlier detection of eye detection and tries to diagnose the problem. Early detection of eye problem helps the patient to have a clear line of sight distance through fuzzy c means clustering algorithm.The tear film must be detected at an early stage to protect the person from death. The tear film should be a monitor at the initial stage and diagnose by the unique technique, whether it may be the invasive or non-invasive method of dry detection. The invasive approach is the time-consuming process, and many disadvantages in this method arise in tear film detection. The non- invasive technique is not said to be a slow process. So the author proposed the novel approach of tear film detection by fuzzy c means clustering algorithm. The sample of eye images are taken and processed with fuzzy c means clustering algorithm and finds the intensity in both the eye. The accuracy analysis carried by fuzzy c indicates a clustering algorithm of 82% in its efficiency.","PeriodicalId":9138,"journal":{"name":"Biomedical Research-tokyo","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86319934","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
S. Harrak, S. Lemsanes, S. Razine, S. Najem, H. Mrabti, S. Jaba, S. ElMajjaoui, N. Benjaafar, H. Errihani
{"title":"Cutaneous angiosarcoma of the scalp: A case report and literature review","authors":"S. Harrak, S. Lemsanes, S. Razine, S. Najem, H. Mrabti, S. Jaba, S. ElMajjaoui, N. Benjaafar, H. Errihani","doi":"10.35841/0970-938X.32.4.79-83","DOIUrl":"https://doi.org/10.35841/0970-938X.32.4.79-83","url":null,"abstract":"Angiosarcoma (AS) is a rare aggressive sarcoma that occurs mostly in the skin of the head and neck in the elderly population. AS of the scalp is associated with high rates of local recurrence and a poor prognosis. Patients with typical presenting symptoms can be diagnosed clinically, but the precise pathological diagnosis should be performed by an expert pathologist. Angiosarcoma requires aggressive and comprehensive treatment by a multidisciplinary team, because a multimodal approach improves survival. The mainstay of treatment is surgical resection and adjuvant radiation therapy, but failure rates following local therapy are high. The chemotherapy is used in cases of metastatic or unresectable scalp angiosarcoma. We describe the case of a 38-year-old woman who presented with lesions nodular on the scalp. The biopsy with histological study demonstrated an angiosarcoma. A computed tomography scan revealed multiple pulmonary metastasis, she received intravenous paclitaxel, the scalp and lung lesions significantly diminished after 3 month of treatment.","PeriodicalId":9138,"journal":{"name":"Biomedical Research-tokyo","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90678435","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Cellular expression and subcellular localization of diacylglycerol kinase γ in rat brain.","authors":"Yasukazu Hozumi, Tomoyuki Nakano, Kaoru Goto","doi":"10.2220/biomedres.42.33","DOIUrl":"https://doi.org/10.2220/biomedres.42.33","url":null,"abstract":"<p><p>Gq protein-coupled receptors lead to activation of phospholipase C, which triggers phosphoinositide signaling. Diacylglycerol (DG) is one of the phosphoinositide metabolites and serves as a second messenger. Diacylglycerol kinase (DGK) phosphorylates DG to produce another second messenger phosphatidic acid. Of the DGK family, DGKγ is predominantly expressed in the brain at the mRNA level. Recent studies have shown the expression of DGKγ in vascular endothelial cells and adrenal medullary cells at the protein level, although its detailed cellular expression pattern and subcellular localization in the brain remain to be determined. In the present study, we addressed this point using specific DGKγ antibody. DGKγ was expressed in both projection neurons and interneurons in the cerebral cortex, hippocampal formation, and cerebellum. In cerebellar Purkinje cells, DGKγ was distributed to the soma and dendrites. Fractionation study revealed that DGKγ was enriched in the internal membranes containing the endoplasmic reticulum and Golgi complex. In immunoelectron microscopy, DGKγ was localized throughout the smooth endoplasmic reticulum system. These findings suggest that DGKγ shows unique cellular expression pattern in the brain and distinct subcellular localization different from other DGK isozymes.</p>","PeriodicalId":9138,"journal":{"name":"Biomedical Research-tokyo","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25353635","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Cellular expression of CD26/dipeptidyl peptidase IV.","authors":"Toshihiko Iwanaga, Junko Nio-Kobayashi","doi":"10.2220/biomedres.42.229","DOIUrl":"https://doi.org/10.2220/biomedres.42.229","url":null,"abstract":"<p><p>Dipeptidyl peptidase 4 (DPP4), a serine protease expressed on luminal and apical cell membrane, is identical to the lymphocyte cell surface protein CD26. DPP4 rapidly deactivates hormones and cytokines by cleaving their NH<sub>2</sub>-terminal dipeptides. Its functions are based on membrane digestion and/or binding of bioactive peptides, signal molecules, and extracellular matrix components. The soluble form is also present in body fluids such as serum, urine, semen, and synovial fluid. The extremely broad distribution of CD26/DPP4 indicates its divergent roles depending on cell type and activated conditions. The cellular localization was earlier examined by enzyme histochemistry and subsequently by immunohistochemistry. Although immunohistochemical analyses are higher in specificity and easier to use at electron microscopic levels than enzyme histochemistry, the immunoreaction is considerably affected by the animal species, types of tissue sections, and specificity of antibodies. Understanding of the functional significance and advancement of its clinical use (diagnosis and treatment of diseases) require precise information on the cellular distribution including subcellular localization and pathological changes. This short review summarizes in particular immunohistochemical findings on CD26/DPP4.</p>","PeriodicalId":9138,"journal":{"name":"Biomedical Research-tokyo","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39749586","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
EL Hazzaz Reda, Oualla Karima, Darif Khadija, Sqalli Houssaini Med, Amaadour Lamiae, B. Zineb, A. Samia, M. Nawfel
{"title":"New conjugated monoclonal antibodies: Area of a promising therapy in metastatic breast cancer.","authors":"EL Hazzaz Reda, Oualla Karima, Darif Khadija, Sqalli Houssaini Med, Amaadour Lamiae, B. Zineb, A. Samia, M. Nawfel","doi":"10.35841/0970-938X.32.1.15-18","DOIUrl":"https://doi.org/10.35841/0970-938X.32.1.15-18","url":null,"abstract":"Following advances in molecular biology and better understanding of the mechanisms of carcinogenesis, new therapies have been developed with new agents that target tumor cells with minimal effects on normal cells. Monoclonal antibodies represent the model of success of this approach; they are directed against antigens selectively expressed by tumor cells. The conjugation of these monoclonal antibodies with potent cytotoxic drugs makes it possible to improve their efficacy while maintaining a favorable tolerance profile. T-DM1 (Trastuzumab Emtansine) is the first example of advanced development of a conjugated antibody. It works by associating an antitumor activity specific to trastuzumab with the efficient delivery of a potent cytotoxic, delivered selectively and targeted to cancer cells overexpressing HER2. Unlike trastuzumab emtansine, trastuzumab deruxtecan has a released payload that easily crosses the cell membrane, which potentially allows for a potent cytotoxic effect on neighboring tumor cells regardless of target expression. In addition, the released payload has a short half-life, which is designed to minimize systemic exposure. DESTINY breast-01 study has demonstrated the efficacy of trastuzumab deruxtecan in patients with HER2- positive metastatic breast cancer previously treated with trastuzumab emtansine. Trastuzumab deruxtecan is FDA-approved. Sacituzumab govitecan (sacituzumab govitecan-hziy) is a conjugated monoclonal antibody developed by site-specific conjugation of the active metabolite of irinotecan, SN-38 (govitecan). It has demonstrated promising activity in advanced lines for triple-negative breast cancer in a phase I/II study and recently in ASCENT trial phase III. Conjugated monoclonal antibodies have been shown to be effective in different subtypes of metastatic breast cancer.","PeriodicalId":9138,"journal":{"name":"Biomedical Research-tokyo","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84047698","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Julia Koseki, Takahiro Abe, Y. Miyamoto, M. Kashiwagi, Makiko Ishibashi, Asako Taniguchi, H. Suenaga, H. Abe, Masanobu Abe, K. Hoshi
{"title":"Use of application of navigation system to odontogenic benign tumors with maxilla.","authors":"Julia Koseki, Takahiro Abe, Y. Miyamoto, M. Kashiwagi, Makiko Ishibashi, Asako Taniguchi, H. Suenaga, H. Abe, Masanobu Abe, K. Hoshi","doi":"10.35841/0970-938X.32.2.37-41","DOIUrl":"https://doi.org/10.35841/0970-938X.32.2.37-41","url":null,"abstract":"Oral and maxillofacial region has a complicated anatomy with critical nerves and arteries inside. Therefore, oral surgeons sometimes do not have enough operative fields during surgeries and anatomic changes caused by tumors and fractures make the surgeries more difficult. The application of navigation system in oral surgery has started in such cases that tumors are close to cranial base and have risks to damage important anatomical structures like nerves and vessels. It can make doctors more confident with their operations and decrease operative risks, but the use is still limited because of several obstacles. In this context, we applied navigation system to the operations of removing recurrent ameloblastoma on sphenoid bone and myxoma. The surgeries we performed with navigation system were successful and we have not had any postoperative complications at all. This report presents to use navigation system to remove benign tumor that occurs in deep area of craniofacial bone completely in a minimally invasive way.","PeriodicalId":9138,"journal":{"name":"Biomedical Research-tokyo","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90361429","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Genomic profiling of multiple tissues in two patients with multiple endocrine neoplasia type 1.","authors":"Akane Naruoka, Sumiko Ohnami, Takeshi Nagashima, Masakuni Serizawa, Keiichi Hatakeyama, Keiichi Ohshima, Shumpei Ohnami, Kenichi Urakami, Yasue Horiuchi, Yoshimi Kiyozumi, Hiroyuki Matsubayashi, Masato Abe, Takuma Ohishi, Toru Kameya, Takashi Sugino, Tetsuro Onitsuka, Mitsuhiro Isaka, Yasuhisa Ohde, Teiichi Sugiura, Takaaki Ito, Katsuhiko Uesaka, Yasuto Akiyama, Masatoshi Kusuhara, Ken Yamaguchi","doi":"10.2220/biomedres.42.89","DOIUrl":"https://doi.org/10.2220/biomedres.42.89","url":null,"abstract":"<p><p>Multiple endocrine neoplasia type 1 (MEN1) is an autosomal dominant tumor syndrome. This hereditary cancer is caused by germline variants in MEN1. Two patients with MEN1 were identified via whole exome sequencing and gene expression profile analysis, conducted for 5,063 patients with various types of cancers. We obtained multiple tumors from each patient; tumors derived from these two MEN1 patients had a loss of the normal MEN1 allele and frequently chromosomal copy number changes. Thus, we investigated whether structural variants were present in the MEN1 patient genomes. Whole-genome sequencing revealed no catastrophic rearrangements, and the tumor samples had very low somatic variants. The two patients had germline variants in MEN1 and some chromosomal copy number changes including on chromosome 11. The only pathogenic variant detected was the MEN1 germline variant, and chromosomal rearrangements led to tumorigenesis in somatic cells. Furthermore, the MEN1 tumor samples displayed a specific signature characterized by T:A>C:G transition. Studies of multiple tumors obtained from single patients are rare in hereditary cancer syndromes, and our results provide insights that the second hit of the tumor suppressor gene MEN1 may be caused by a gross genome rearrangement, not a small insertion and deletion, nor a change in epigenetic regulation.</p>","PeriodicalId":9138,"journal":{"name":"Biomedical Research-tokyo","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25589574","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
M. C. Lucendo, C. RosarioIsabel, O. Pilatuna, Diego Arm, O. S. Pazos, Juan Alberto Coloma, C. González, César Rotawisky, Carlos Steven Marmolejo Escobar, Sebastián Ospina Otalvaro, Karen Julieth Quebrada Mera, Valentina Triana Díaz, P. Lenis, Delia Cristina Hernández, Pablo Miguel Arango de la Pava, María Eugenia Barrera Robledo, Juliana Vergel, Valentina Herrera Montoya, N. Hernandez, Jeannette Sanchez
{"title":"Executive functions in patients with different types of headaches.","authors":"M. C. Lucendo, C. RosarioIsabel, O. Pilatuna, Diego Arm, O. S. Pazos, Juan Alberto Coloma, C. González, César Rotawisky, Carlos Steven Marmolejo Escobar, Sebastián Ospina Otalvaro, Karen Julieth Quebrada Mera, Valentina Triana Díaz, P. Lenis, Delia Cristina Hernández, Pablo Miguel Arango de la Pava, María Eugenia Barrera Robledo, Juliana Vergel, Valentina Herrera Montoya, N. Hernandez, Jeannette Sanchez","doi":"10.35841/0970-938X.32.3.S10-S16","DOIUrl":"https://doi.org/10.35841/0970-938X.32.3.S10-S16","url":null,"abstract":"Patients suffering from headache complain of the appearance of cognitive symptoms, although there is not much research in this regard, so the objective of the study was to analyze the deterioration in executive functions in patients with different types of headaches. The executive functions are processes related to the planning of the behaviour oriented to the achievement of a goal. A cross-sectional study was carried out, with a sample of 48 participants; 18 with vascular headache, 14 with tension headache, 16 with migraine. Significant differences have been found in the capacity for abstraction, which has discriminated between patients with vascular headache and tension headache, as well as between these and patients with migraine. Similarly, overall cognitive performance is different in patients with migraine compared with patients with vascular headache and tension headache. The type of headache and global cognitive impairment moderately affect the variability of abstraction capacity. Finally, the existence of a directly proportional relation of positive nature that indicates a dependent between the variables has been evidenced. It can be concluded that global cognitive deterioration affects the performance of abstraction capacity.","PeriodicalId":9138,"journal":{"name":"Biomedical Research-tokyo","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88141313","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"A rare presentation of endobronchial metastasis from renal cell carcinoma resected 120 months after nephrectomy.","authors":"Emine Ozsari, S. Ozer, D. Oğuz","doi":"10.35841/0970-938X.32.3.S17-S20","DOIUrl":"https://doi.org/10.35841/0970-938X.32.3.S17-S20","url":null,"abstract":"Introduction: Multipl extrapulmonary tumors can metastasize to the bronchus. Endobronchial Metastases (EBM) should be distinguished from these tumors because of their poor prognosis and different treatments. Case presentation: A 70-year-old male patient was admitted with thorax computed tomography, which was taken with the complaints of increasing cough and weight loss. The patient who had a history of left nephrectomy due to renal cell carcinoma 10 years ago did not have a history of receiving postoperative chemotherapy/radiotherapy. In bronchoscopy, the right lung upper lobe anterior subsegment entry was obliterated with an endobronchial lesion. The histopathological appearance was consistent with clear cell renal cell carcinoma metastasis Conclusion: This case is presented to emphasize that EBM may mimic primary lung cancers especially with respiratory symptoms. Ten years’ time interval is the longest period between radical nephrectomy and EBM in literature.","PeriodicalId":9138,"journal":{"name":"Biomedical Research-tokyo","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86815889","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Effect on malondialdehyde, superoxide dismutase and reduced glutathione and its metabolizing enzymes in vitamin D deficient newly diagnosed Type- 2 diabetic patients.","authors":"Kuldip Singh","doi":"10.35841/0970-938X.32.1.1-6","DOIUrl":"https://doi.org/10.35841/0970-938X.32.1.1-6","url":null,"abstract":"Background: India, with 32 million diabetic individuals, currently has the highest incidence of diabetes worldwide. Recently, World Health Organization (WHO) reported that these numbers are predicted to increase to 80 million by the year 2030. Vitamin D regulates glucose metabolism and oxidative stress is a well-established factor of this multi-factorial disease. Aim: Present, study was designed to evaluate certain oxidative stress markers like malondialdehyde, superoxide dismutase, reduced glutathione, glutathione reductase, Glutathione Peroxidase (GPx) along with total antioxidant activity in vitamin D deficient newly diagnosed Type 2 diabetics. Methods: 150 vitamin D deficient newly diagnosed type 2 diabetics’ and equal number of healthy subjects of both genders were recruited. Fasting blood was collected for evaluation of glucose, 25(OH) D and oxidative stress markers. Results: Significant (P<0.01) increase in malondialdehyde by 51.03% while a significant decrease in oxidative stress markers like SOD, GSH, GR, GPx and total antioxidant activity by 27.91 (P<0.05), 26.14% (P<0.05), 32.04% (P<0.01), 25.41% (P<0.05) and 35.85% (P<0.01) respectively was recorded in vitamin D deficient newly diagnosed type 2 diabetics with respect to healthy controls. Conclusions: A fore mentioned observations suggested that vitamin-D deficient newly diagnosed Type-2 diabetics of North-West Indian’s are associated with oxidative stress, a hallmark of various diseases like Diabetes Mellitus, cardiovascular diseases, osteoporosis etc. Therapeutic interventions in combinations of lifestyle and dietary modification might be beneficial to prevent further risk of development of Diabetes Mellitus and cardiovascular diseases like atherosclerosis in North-West Indians.","PeriodicalId":9138,"journal":{"name":"Biomedical Research-tokyo","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79910112","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}